Physician Assistant, Medical · Baltimore, MD
NPI
1326480716
Since 2013
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2835 Smith Ave, Suite 207
Baltimore, MD, 21209
Phone (410) 358-4243
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$182K
1,499 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Dina Rechthand prescribed most often to Medicare patients was Atorvastatin Calcium, with 161 prescriptions and refills. In total Dina Rechthand wrote 1,499 Medicare prescriptions that cost $182K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 161 | 241 | 33 | $2,966 |
| Pantoprazole Sodium Generic | 57 | 68 | Under 11 | $489 |
| Metformin Hcl Generic | 52 | 73 | 13 | $476 |
| Omeprazole Generic | 52 | 61 | Under 11 | $537 |
| Furosemide Generic | 50 | 79 | Under 11 | $219 |
| Levothyroxine Sodium Generic | 47 | 68 | Under 11 | $537 |
| Metoprolol Succinate Generic | 44 | 80 | Under 11 | $922 |
| Simvastatin Generic | 43 | 52 | Under 11 | $320 |
| Amlodipine Besylate Generic | 40 | 86 | 11 | $238 |
| Demeclocycline Hcl Generic | 37 | 37 | Under 11 | $37K |
| Hydrochlorothiazide Generic | 32 | 60 | Under 11 | $132 |
| Montelukast Sodium Generic | 31 | 39 | Under 11 | $428 |
| Trazodone Hcl Generic | 27 | 51 | Under 11 | $828 |
| Lisinopril Generic | 26 | 29 | Under 11 | $97.69 |
| Rosuvastatin Calcium Generic | 26 | 74 | Under 11 | $655 |
Brand drugs: 169 claims; generic drugs: 1,319 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Dina Rechthand were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.